HMOX1 and gastrointestinal stromal tumor: As shown in Figure 6L, western blot analysis showed that the NRF2 levels were highly increased in the GIST cells with β‐elemene treatment, compared to control and imatinib alone, accompanied by the upregulation of HMOX1.